MFDS — authorised 1 December 2020
- Marketing authorisation holder: UNIV CA LOS ANGELES
- Status: likely_approved
🇰🇷 Locametz in South Korea
MFDS authorised Locametz on 1 December 2020
Marketing authorisation
Locametz in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Locametz approved in South Korea?
Yes. MFDS authorised it on 1 December 2020.
Who is the marketing authorisation holder for Locametz in South Korea?
UNIV CA LOS ANGELES holds the South Korean marketing authorisation.